Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Revenue (Most Recent Fiscal Year) | $1.08B |
Net Income (Most Recent Fiscal Year) | $-434.80M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 9.74 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 13.71 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -40.14% |
Net Margin (Trailing 12 Months) | -40.16% |
Return on Equity (Trailing 12 Months) | -62.19% |
Return on Assets (Trailing 12 Months) | -31.88% |
Current Ratio (Most Recent Fiscal Quarter) | 4.10 |
Quick Ratio (Most Recent Fiscal Quarter) | 3.96 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.37 |
Inventory Turnover (Trailing 12 Months) | 14.19 |
Book Value per Share (Most Recent Fiscal Quarter) | $6.37 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.64 |
Earnings per Share (Most Recent Fiscal Year) | $-3.78 |
Diluted Earnings per Share (Trailing 12 Months) | $-3.79 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Common Shares Outstanding | 120.76M |
Free Float | 109.38M |
Market Capitalization | $10.54B |
Average Volume (Last 20 Days) | 1.12M |
Beta (Past 60 Months) | 1.37 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 9.42% |
Percentage Held By Institutions (Latest 13F Reports) | 99.90% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |